(S)-N-(2-PROPYNYL)-2,3-DIHYDROINDEN-1-AMINE, 97.0%, 100mg

4-Methylpyrimidin-5-ol, 97%, 100mg

9-(4,6-dichloro-1,3,5-triazin-2-yl)-9H-carbazole, 98+%, 10g

3-(Trifluoromethyl)phenylurea, 95.0%, 10g

N-Carboxymethylrhodanine, 95.0%, 5g

2-(3-((Tert-butoxycarbonyl)amino)cyclobutyl)acetic acid, 98%, 5g

(3-(Piperidin-1-ylsulfonyl)phenyl)boronic acid, 98.0%, 25mg

4'-Butylacetophenone, 97.0%, 25g

GC capillary column ROTI®Cap-1701, 30 m, 0.32 mm, 1.00 µm, 1 Piece(s)

(2S)-1-(Pyridin-2-yl)pyrrolidine-2-carboxylic acid hydrochloride, 97%, 1g

tert-butyl N-[(3R,4S)-4-fluoropiperidin-3-yl]carbamate, 97.0%, 500mg

7-Iodopyrrolo[2,1-f][1,2,4]triazin-4-amine>98.0%(HPLC)(T)5g

L(-)-lactic acid ethyl ester, min. 96%, 1 l, plastic packaging.